CN · Field Manual
MANUAL 01 · READING A CLAIM REAL RELEASED DATA
Learn the system / Manual 01

How to read
a claim record.

~5 minUses sheet MFI-TURMER-20261008-FSNo tooling required

One claim is one accountable object

Every claim in a sheet is a single record that binds a relation (subject → outcome), a direction, the doses and durations actually reported, a grade ceiling with its basis, and the evidence — supporting and opposing — that produced it. Nothing about the claim is free-floating prose; every field traces to a source row.

The grade is a ceiling, not a rating

The grade on the header is the strongest statement the weakest dimension can carry. The eight-cell basis grid shows why: seven grading dimensions plus the bound-study count. A claim with HIGH design evidence still reads VERY_LOW if confidence or methodology is weak — the weakest cell sets the ceiling. Manual 02 walks through this rule.

Bound studies carry their own verdicts

Each study row shows design type, model, year, duration, and its risk-of-bias assessment. INSUFFICIENT_INFORMATION is a real verdict, not a gap — it means the record was assessed and the reporting didn't support a stronger call.

Opposition is bound, not buried

Below the observations sits the opposition screen — records considered against the claim, with their verdicts. Rejections carry reasons. If a source contradicted the claim and was bounded out, it appears here.

Key to the record
AClaim identity + grade ceiling — the object ID and the honest maximum.
BRelation — subject, arrow, outcome. What the claim actually asserts.
CDirection, dose set, duration set — as reported across bound studies, not normalized away.
DGrade basis — seven weakest-link dimensions + bound study count.
EBound studies — typed, dated, RoB-assessed, endpoint-counted.
FQuantitative observations + opposition verdicts.
ANNOTATED RECORD
RECORD ANATOMY · FIELD RECORDREAL RELEASED DATA — MFI-TURMER-20261008-FS
CLAIM · CLM-6a6b7e456bdbc1b7 AGRADE VERY_LOW
turmeric constituents — inflammation B
direction BENEFIT · dose 120 mg; 150 mg/kg; 1500 mg; 500 mg; 80 mg · duration 12 months; 14 day; 21 days; 3 months; 30 days; 42 days; 84 days; 90 days C
Grade basis — weakest-link ceilings D
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
LOWmethodology
MODERATEconsistency
MODERATEnumeric
39bound studies
Bound studies (4 shown of 39) E
STU-038efdb3b38b48b3
ANIMAL · 2018 · 42 days · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-07933ddb977eea41
ANIMAL · 2025 · 30 days · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-0efd886e36fc1a4d
IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-1fcddeaa54b69e34
META_ANALYSIS · HUMAN · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations F
IL-6 −0.42 SMD-type effect · 95% interval reported · extracted verbatim
CRP direction-only · no usable interval · flagged, not estimated
Opposition screen
BOUND · 2 candidate records contradicted direction — retained against the claim
REJECTED · 1 candidate screened out — population mismatch, reason recorded
← All manuals Manual 02 — Weakest-link grading →